Hui Quan

ORCID

Publication Activity (10 Years)

Years Active: 2018-2024
Publications (10 Years): 14

Top Venues

Pharmaceutical statistics

Statistics in medicine

Sanofi

Columbia University (PHD)

This page only lists publications with an associated author ORCID identifier.

Affiliation History

Sanofi Sep 26 2005

United States

Associate VP :: Biostatistics and Programming

Education History

Columbia University Aug 28 1986 - Oct 15 1990

United States

PHD :: Statistics

Publications

Yanping Chen, Yong Lin, Shou-En Lu, Weichung Joe Shih, Hui Quan
Two-stage stratified designs with survival outcomes and adjustment for misclassification in predictive biomarkers. Statistics in medicine 43 (10) (2024)
Ahrim Youn, Jiarui Chi, Yue Cui, Hui Quan
A case study: Assessing the efficacy of the revised dosage regimen via prediction model for recurrent event rate using biomarker data. Pharmaceutical statistics 23 (4) (2024)
Yanping Chen, Yong Lin, Shou-En Lu, Weichung Joe Shih, Hui Quan
Two-stage stratified designs with survival outcomes and adjustment for misclassification in predictive biomarkers. Statistics in medicine 43 (10) (2024)
Yanping Chen, Yong Lin, Shou-En Lu, Weichung Joe Shih, Hui Quan
Two-stage stratified designs with survival outcomes and adjustment for misclassification in predictive biomarkers. Statistics in medicine 43 (10) (2024)
Yanping Chen, Yong Lin, Shou-En Lu, Weichung Joe Shih, Hui Quan
Two-stage stratified designs with survival outcomes and adjustment for misclassification in predictive biomarkers. Statistics in medicine 43 (10) (2024)
Ahrim Youn, Jiarui Chi, Yue Cui, Hui Quan
A case study: Assessing the efficacy of the revised dosage regimen via prediction model for recurrent event rate using biomarker data. Pharmaceutical statistics (2024)
Yanping Chen, Yong Lin, Shou-En Lu, Weichung Joe Shih, Hui Quan
Two-stage stratified designs with survival outcomes and adjustment for misclassification in predictive biomarkers. Statistics in medicine 43 (10) (2024)
Hui Quan, Tong Li, Xun Chen, Gang Li
Generalizing Treatment Effect to a Target Population Without Individual Patient Data in a Real-World Setting. Pharmaceutical statistics (2024)
Hui Quan, Zhixing Xu, Junxiang Luo, Gautier Paux, Meehyung Cho, Xun Chen
Utilization of treatment effect on a surrogate endpoint for planning a study to evaluate treatment effect on a final endpoint. Pharmaceutical statistics (2023)
Hui Quan, Xiaofei Chen, Junxiang Luo, Xun Chen
A generalized weighted combination test of treatment effect for clinical trials with a sequential parallel comparison design and binary endpoint. Statistics in medicine 41 (15) (2022)
Zhixing Xu, Hui Quan
Bivariate Bayesian hypothesis testing with missing data in components. Pharmaceutical statistics (2021)
Hui Quan, Xun Chen, Yu Lan, Xiaodong Luo, Rene Kubiak, Nicolas Bonnet, Gautier Paux
Applications of Bayesian analysis to proof-of-concept trial planning and decision making. Pharmaceutical statistics 19 (4) (2020)
Xiaodong Luo, Xuezhou Mao, Xun Chen, Junshan Qiu, Steven Bai, Hui Quan
Design and monitoring of survival trials in complex scenarios. Statistics in medicine 38 (2) (2018)
Hui Quan, Yi Xu, Yixin Chen, Lei Gao, Xun Chen
A case study of an adaptive design for a clinical trial with 2 doses and 2 endpoints in a rare disease area. Pharmaceutical statistics 17 (6) (2018)

Hui Quan.css-eqlu8i{font-size:small;padding-left:4px;}

Publication Activity (10 Years)

Top Topics

Top Venues

Hui Quan